"Twelfth Five-Year Plan" Supports Biopharmaceuticals into Golden Age

"Twelfth Five-Year" Policy Support Biopharmaceuticals Entering Golden Phase - BioPh China 2012 Leads New Industry

On November 28, 2011, the Ministry of Science and Technology released the “12th Five-Year Plan for Biotechnology Development”, stating that it will establish a multi-channel investment mechanism, increase financial and taxation financial support policies, and promote the overall biotechnology of China during the “12th Five-Year Plan” period. We entered the world advanced level and promoted the rapid rise of industries such as bio-pharmaceuticals, bio-agriculture, bio-manufacturing, bio-energy, and bio-environmental protection. The overall layout of the bio-industry has basically taken shape. It has promoted the bio-industries to become one of the pillar industries of the national economy, making China a bio-technological power. And biological industry.
According to the “Planning”, the total output value of biopharmaceuticals during the 12th Five-Year Plan period will increase by 20% annually and reach 3.1 trillion Yuan by 2015; the industrial added value will increase by 20% annually and reach 1.2 trillion Yuan by 2015. At the same time, the central and local financial support funds will double in size from the “Eleventh Five-Year Plan” to 40 billion yuan.
Policy encouragement and capital support will bring more vitality to the development of the biopharmaceutical industry, and Chinese pharmaceutical companies will also seek new opportunities in the development of biopharmaceuticals and technology. In this context, the hot spots of the Twelfth World Pharmaceutical Ingredient China Exhibition (CPhI China 2012) came into being. For the first time in the exhibition, BioPh China, a biopharmaceutical and technology zone, will be launched to provide Chinese pharmaceutical companies with an opportunity to enhance their market competitiveness and expand their broader biomedical market. As an important part of the exhibition, BioPh China focuses on the display of products and technologies such as genetic engineering, antibody engineering, and cell engineering, and will provide the best exchange trading platform for biopharmaceutical companies, biotechnology companies, new drug R&D companies, and professionals!
BioPh China currently has Dongbao Industry Group, Pantech Pharmaceuticals, Changchun Baike, Anhui Anke, Changzhou Qianhong, Shenzhen Maxico, Chengdu Capgemini, Xiamen Turbo, Changchun Jinsai, Shenzhen Hanyu, Guangdong Tempo and other organisms Leading pharmaceutical companies confirmed their participation in the exhibition. The exhibition site will also set up high-end thematic forums, inviting industry experts, scholars, and senior technical elites from well-known companies to jointly discuss the latest developments in biopharmaceuticals. It will then present to the audience a biopharmaceutical at the forefront of the industry. feast!
We look forward to meeting you on June 26-28, 2012 at Shanghai New International Expo Center (2345 Longyang Road)!

Exhibitors' Express:
Chengdu Kaijie Biomedical Technology Development Co., Ltd.
Chengdu Kaijie Bio-pharmaceutical Technology Development Co., Ltd. is a high-tech enterprise specializing in polypeptide drug production and R&D. Its main business is the production of peptide raw materials, the synthesis of peptide samples for scientific research, and the development of industrial production processes for polypeptide drugs. The company's customers are mainly large-scale contract pharmaceutical factories in North America and Europe. It has more than 1,300 companies and R&D institutions in 69 countries around the world.
Xiamen Tebao Bioengineering Co., Ltd. was founded in 1994 and specializes in the development of genetic engineering products and the industrialization of biomedicine. It is a high-tech enterprise integrating R&D, production and sales. Has now independently developed two types of new biological products on the market in three countries: recombinant human granulocyte macrophage stimulating factor (teleline), recombinant human granulocyte stimulating factor (tertin), and recombinant human interleukin-11 (special Erkang), another five therapeutic gene engineering protein drugs (rhIFN alpha-2a, rhIFN alpha-2b, rhGH, rhIL-2, rhIFNgamma) have obtained clinical research approvals and are currently in the clinical research stage.
Changchun Biotech Unit Clinical Research Phase Company
The company is located in Changchun High-tech Industrial Development Zone, established in March 2004. It is a high-tech enterprise integrating R&D, production and sales of new drugs. The company's vaccine research laboratory is constructed in accordance with the GLP standard, and comprehensively applies theories and experimental techniques such as biochemistry, molecular biology, and immunology to carry out gene engineering vaccines, protein peptide vaccines, polysaccharide vaccines, conjugate vaccines, DNA vaccines, and viral vector vaccines. Fundamental research on vaccines and transformation of results, while carrying out traditional vaccine improvement work, promoting the research of new technologies in the field of vaccine research and the upgrading of traditional vaccines;
At present, the online pre-registration system has been opened for the viewers. Those who pre-register in advance can receive a gift at the scene, and they can also avoid queuing at the scene. Welcome to register now: http://?fair_id=144.
Exhibition background:
The "World Pharmaceutical Raw Materials China Exhibition" and the "CpII, ICSE & BioPh China" exhibition were organized by UBM International Media and the China Chamber of Commerce for Import & Export of Medicinal Products. Shanghai Bo China International Exhibition Co., Ltd. co-organized, exhibiting raw materials, chemical products and intermediates, excipients and dosage forms, natural extracts, contract R&D outsourcing, contract production outsourcing, reagents, biotechnology, etc. It is the largest and highest level in Asia. The most influential pharmaceutical industry trading platform. In 2012, the exhibition will be held in "2012 World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition (P-MEC China 2012)" and "2012 World Biochemistry, Analytical Instruments and Laboratory Equipment China Exhibition" (LABWorld China 2012) in June 2012. The 26-28th was held at the Shanghai New International Expo Center.

Platform Trolley

Platform Trolley,Folding Platform Hand Truck,Platform Push Cart,Stainless Steel Platform Trolley

Dalian CS Logistics Technology Co., Ltd , https://www.dlcsems.com